Zobrazeno 1 - 10
of 82
pro vyhledávání: '"David Aboulafia"'
Autor:
Thomas M. Atkinson, Kathleen A. Lynch, Jacqueline Vera, Nuria Mendoza Olivares, Andrew Webb, Lisa C. Diamond, Javier González, Erica I. Lubetkin, Gary Bucher, Isabella Rosa-Cunha, J. Michael Berry-Lawhorn, Rebecca Levine, David Aboulafia, Jeffrey Schouten, Susan M. Holland, David Cella, Joel M. Palefsky
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-7 (2022)
Abstract Objectives The Anal Cancer High-grade squamous intraepithelial lesions (HSIL) Outcomes Research (ANCHOR) Health-Related Symptom Index (A-HRSI) is a 25-item measure that assesses physical symptoms and impacts, and psychological symptoms. To p
Externí odkaz:
https://doaj.org/article/f520ada708ec404fb61c5f11157a1347
Autor:
Charles L. Bennett, Nancy Olivieri, Shamia Hoque, David Aboulafia, Anne Ventrone, Courtney Lubaczewski, Betty Dong, Benjamin Schooley, Bartlett J. Witherspoon, Paul S. Ray, William J. Hrushesky, John Restaino, Henrik S. Thomsen, Dennis Mangano, Christina Mora-Mangano, June M. McKoy, Martin Schoen, Kevin Knopf, Linda Martin, Steven Rosen
Publikováno v:
The Journal of Scientific Practice and Integrity (2022)
# Background We previously described experiences of clinicians who published adverse drug reaction reports. We now report on threats and intimidations leveled against clinicians and scientists who received publicly documented threats after communica
Externí odkaz:
https://doaj.org/article/c58a1f473a3e44cfa3fb8a9e0941656a
Autor:
Charles L. Bennett, Shamia Hoque, Nancy Olivieri, Matthew A. Taylor, David Aboulafia, Courtney Lubaczewski, Andrew C. Bennett, Jay Vemula, Benjamin Schooley, Bartlett J. Witherspoon, Ashley C Godwin, Paul S. Ray, Paul R. Yarnold, Henry C. Ausdenmoore, Marc Fishman, Georgne Herring, Anne Ventrone, Juan Aldaco, William J. Hrushesky, John Restaino, Henrik S. Thomsen, Robert Marx, Cesar Migliorati, Salvatore Ruggiero, Chadi Nabhan, Kenneth R. Carson, June M. McKoy, Y. Tony Yang, Martin W. Schoen, Kevin Knopf, Linda Martin, Oliver Sartor, Steven Rosen, William K. Smith
Publikováno v:
EClinicalMedicine, Vol 31, Iss , Pp 100693- (2021)
Background: Adverse drug/device reactions (ADRs) can result in severe patient harm. We define very serious ADRs as being associated with severe toxicity, as measured on the Common Toxicity Criteria Adverse Events (CTCAE)) scale, following use of drug
Externí odkaz:
https://doaj.org/article/7660e72814e34fe8aaa2b0680f081e61
Autor:
Joseph A. Sparano, Jeannette Y. Lee, Lawrence D. Kaplan, Juan Carlos Ramos, Richard F. Ambinder, William Wachsman, David Aboulafia, Ariela Noy, David H. Henry, Lee Ratner, Ethel Cesarman, Amy Chadburn, Ronald Mitsuyasu
Publikováno v:
Haematologica, Vol 106, Iss 3 (2020)
Four cycles of rituximab plus CHOP chemotherapy is as effective as 6 cycles in low-risk diffuse large B-cell lymphoma (DLBCL). Here we report a post-hoc analysis of a prospective clinical trial in patients with HIV-associated DLBCL and high-grade lym
Externí odkaz:
https://doaj.org/article/078d20628e604f39b442cee01904788e
Supplementary Data from AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma
Autor:
William Wachsman, Ronald Mitsuyasu, Robert Baiocchi, Toby Maurer, Elizabeth Yu Chiao, David Aboulafia, Dirk P. Dittmer, Otoniel Martínez-Maza, Semi Han, Jack D. Bui, Richard F. Ambinder, Page Moore, Kelly Shimabukuro, Erin G. Reid
Supplementary Data from AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::363d84ff46d51c141fc72087788491a6
https://doi.org/10.1158/1078-0432.22482903.v1
https://doi.org/10.1158/1078-0432.22482903.v1
Autor:
William Wachsman, Ronald Mitsuyasu, Robert Baiocchi, Toby Maurer, Elizabeth Yu Chiao, David Aboulafia, Dirk P. Dittmer, Otoniel Martínez-Maza, Semi Han, Jack D. Bui, Richard F. Ambinder, Page Moore, Kelly Shimabukuro, Erin G. Reid
Purpose:Kaposi sarcoma (KS), an endothelial cell tumor associated with KS herpesvirus (KSHV), remains among the most common malignancies occurring with HIV infection (HIV-KS). As an oral anti-inflammatory, antiangiogenic, and immunomodulatory agent,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84574c6515d7cf55b78e89e9903fa915
https://doi.org/10.1158/1078-0432.c.6531033
https://doi.org/10.1158/1078-0432.c.6531033
Autor:
William Wachsman, Mark A. Dickson, Ronald Mitsuyasu, David Aboulafia, Robert J. Gorelick, Frank Maldarelli, Richard F. Ambinder, Dirk P. Dittmer, Shelly Y. Lensing, Adrienne Suazo, Erin G. Reid
Purpose:AIDS-related Kaposi sarcoma is often incompletely controlled, requiring serial therapies. Kaposi sarcoma herpesvirus (KSHV) induces transformation of endothelial cells, where it resides in a predominately latent state. We hypothesized proteas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::670457123e4178159acb057973d5f431
https://doi.org/10.1158/1078-0432.c.6528564.v1
https://doi.org/10.1158/1078-0432.c.6528564.v1
Autor:
William Wachsman, Mark A. Dickson, Ronald Mitsuyasu, David Aboulafia, Robert J. Gorelick, Frank Maldarelli, Richard F. Ambinder, Dirk P. Dittmer, Shelly Y. Lensing, Adrienne Suazo, Erin G. Reid
Supplementary Methods and Figure Supplemental Figure 1. Images demonstrating improvement in KS lesions in two patients obtaining partial response to bortezomib despite receiving treatment in the lowest 2 dose cohorts. Both patients met criteria for p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66c348a9a96cbc4eca2aaeaf9514e187
https://doi.org/10.1158/1078-0432.22473618
https://doi.org/10.1158/1078-0432.22473618
Autor:
Erin G, Reid, Kelly, Shimabukuro, Page, Moore, Richard F, Ambinder, Jack D, Bui, Semi, Han, Otoniel, Martínez-Maza, Dirk P, Dittmer, David, Aboulafia, Elizabeth Yu, Chiao, Toby, Maurer, Robert, Baiocchi, Ronald, Mitsuyasu, William, Wachsman
Publikováno v:
Clinical Cancer Research. 28:2646-2656
Purpose:Kaposi sarcoma (KS), an endothelial cell tumor associated with KS herpesvirus (KSHV), remains among the most common malignancies occurring with HIV infection (HIV-KS). As an oral anti-inflammatory, antiangiogenic, and immunomodulatory agent,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca0643668b6ced2da1f0005aa91d578
https://doi.org/10.1158/1078-0432.ccr-21-0645
https://doi.org/10.1158/1078-0432.ccr-21-0645
Publikováno v:
International Journal of Cancer Care and Delivery. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5aa830e3dd2bfeaed8d5a31c437c96f
https://doi.org/10.53876/001c.36145
https://doi.org/10.53876/001c.36145